Patents by Inventor Glenn Croston

Glenn Croston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment using selective 5-HT2A inverse agonists
    Patent number: 9765053
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: September 19, 2017
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen, Allan Kjaersgaard Uldam
  • METHODS OF TREATMENT USING SELECTIVE 5-HT2A INVERSE AGONISTS
    Publication number: 20170165273
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: March 21, 2011
    Publication date: June 15, 2017
    Inventors: Carl-Magnus A. ANDERSSON, Glenn Croston, Eva Louise Hansen, Allan Kjaersgaard Uldam
  • AZACYCLIC COMPOUNDS
    Publication number: 20160237036
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Application
    Filed: February 16, 2016
    Publication date: August 18, 2016
    Inventors: Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen, Allan Kjaersgaard Uldam
  • Azacyclic compounds
    Patent number: 9296694
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: March 29, 2016
    Assignee: ACADIA PHARMACEUTICALS INC.
    Inventors: Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen, Allan Kjaersgaard Uldam
  • AZACYCLIC COMPOUNDS
    Publication number: 20150259291
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Application
    Filed: February 20, 2015
    Publication date: September 17, 2015
    Inventors: Carl-Magnus A. ANDERSSON, Glenn CROSTON, Eva Louise HANSEN, Allan Kjaersgaard ULDAM
  • METHODS OF TREATMENT USING SELECTIVE 5-HT2A INVERSE AGONISTS
    Publication number: 20110301191
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: March 21, 2011
    Publication date: December 8, 2011
    Inventors: Carl-Magnus A. ANDERSSON, Glenn Croston, E.L. Hansen, Allan Kjaersgaard Uldam
  • AZACYCLIC COMPOUNDS
    Publication number: 20090186921
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: January 16, 2009
    Publication date: July 23, 2009
    Applicant: ACADIA PHARMACEUTICALS, INC.
    Inventors: Carl-Magnus A. Andersson, Glenn Croston, E. L. Hansen, Allan Kjaersgaard Uldam
  • Azacyclic compounds
    Publication number: 20060194834
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: May 3, 2006
    Publication date: August 31, 2006
    Inventors: Carl-Magnus Andersson, Glenn Croston, E. Hansen, Allan Uldam
  • Azacyclic compounds
    Publication number: 20060194778
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
    Type: Application
    Filed: May 3, 2006
    Publication date: August 31, 2006
    Inventors: Carl-Magnus Andersson, Glenn Croston, E. Hansen, Allan Uldam
  • Azacyclic compounds
    Publication number: 20050014757
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Application
    Filed: March 16, 2004
    Publication date: January 20, 2005
    Inventors: Carl-Magnus Andersson, Glenn Croston, E.L. Hansen, Allan Uldam
  • Azacyclic compounds
    Patent number: 6815458
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Grant
    Filed: March 6, 2001
    Date of Patent: November 9, 2004
    Assignee: Acadia Pharmaceuticals, Inc
    Inventors: Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen, Allan Kjaersgaard Uldam
  • Azacyclic compounds
    Patent number: 6756393
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: June 29, 2004
    Assignee: Acadia Pharmaceuticals, Inc.
    Inventors: Carl-Magnus A. Andersson, Glenn Croston, Eva L. Hansen, Allan Kjaersgaard Uldam
  • Azacyclic compounds
    Publication number: 20030220316
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Application
    Filed: April 7, 2003
    Publication date: November 27, 2003
    Inventors: Carl-Magnus A. Andersson, Glenn Croston, E. L. Hansen, Allan Kjaersgaard Uldam
  • Azacyclic compounds
    Publication number: 20020004513
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Application
    Filed: March 6, 2001
    Publication date: January 10, 2002
    Inventors: Carl-Magnus A. Andersson, Glenn Croston, E. L. Hansen, Allan Kjaersgaard Uldam